US May Halt J&J Vaccine Due to Concerns About Rare Blood Clots
The FDA and CDC are already halting the use of the COVID-19 vaccine on federal sites.
Federal health agencies in the United States called for an immediate halt on the distribution of the Johnson & Johnson single-dose COVID-19 vaccine after it emerged that six recipients in the country developed a rare disorder leading to blood clots, a report from The New York Times explains.
The FDA announced, alongside the CDC, that both agencies "are recommending a pause in the use of this vaccine out of an abundance of caution."
The agencies wish to pause the administration of the vaccine to give regulators time to investigate any potential link between the rare blood clots and the vaccine.